lupus erythematosus – Page 5 – Communicable Diseases Research

Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity

COVID-19 및 자가면역에서의 인터페론 및 기타 사이토카인, 유전학 및 그 이상

Review

Published on 2021-04-012022-09-11
Journal: Cytokine & growth factor reviews [Category] 유전자 메커니즘,

[키워드] Alpha antibodies antibody antiviral agent Antiviral agents autoantibodies autoantibody Autoimmune Autoimmune disease Autoimmune diseases Autoimmunity B cell cascade Citrullination complement COVID-19 COVID-19 patient COVID-19: antibody cytokine Cytokines Degradation deletions develop Epitopes Extracellular gene defect Gene segment Genetic genetic defect genetic defects genetics glycosylation growth factor Growth factors hematological homozygous hypotheses immunological Immunological studies in vitro induce Infection innate immune interferon Interferon-beta interferons intracellular content intracellular protein intracellular proteins involved lupus erythematosus mechanism MOST neutralization Neutralizing Neutralizing antibodies neutralizing antibody Occurrence Patient POLE posttranslational modifications protease PROTECT proteolysis question regulated Release Research SARS-CoV-2 Seven severe COVID-19 severe inflammation Signaling systemic lupus erythematosus the SARS-CoV-2 Tolerance type 1 interferons virus virus infection virus replication
[DOI] 10.1016/j.cytogfr.2021.01.004 PMC 바로가기 [Article Type] Review

Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study

류마티스 질환 환자의 SARS-CoV-2 감염에 대한 하이드록시클로로퀸 사전 노출의 영향: 인구 기반 코호트 연구

Article

Published on 2021-04-012022-09-11
Journal: Clinical microbiology and infection : the official [Category] 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analysed Arthritis assessment attack rate Clinical data conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 in patient determine disease Effect HCQ HCQ therapy Health Insurance HIRA Hydroxychloroquine in vitro study infection with SARS-CoV-2 infections insurance investigated Korean logistic regression models lupus erythematosus MOST not differ Patient population-based cohort pre-exposure prophylaxis Prevent Prophylactic retrospective cohort study review rheumatic disease Rheumatic diseases rheumatoid arthritis SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 SLE student suggested systemic lupus erythematosus T-tests tested treated Treatment Usual dose
[DOI] 10.1016/j.cmi.2020.12.003 PMC 바로가기 [Article Type] Article

SARS-CoV-2 vaccines in patients with SLE

Brief Communication

Published on 2021-03-082024-09-04
Journal: Lupus science & medicine [Category] 대상포진,

[키워드] Inflammation lupus erythematosus systemic vaccination
[DOI] 10.1136/lupus-2021-000479 PMC 바로가기 [Article Type] Brief Communication

COVID-19 and autoimmune diseases

코로나19와 자가면역질환

Review

Published on 2021-03-012022-09-11
Journal: Current opinion in rheumatology [Category] SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome association Asymptomatic autoantibodies Autoimmune autoimmune conditions Autoimmune disease Autoimmune diseases Autoimmune response autoimmune responses Autoimmunity caused clinical manifestations conditions coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 in patient COVID-19 infection COVID-19 infections COVID-19 patient COVID-19 patients cross-reactivity develop disease evaluate hallmark host cells immune reaction immune response immune responses infected individual infected individuals Infection infection risk infection with SARS-CoV-2 Infectious disease lupus erythematosus medication organ Pathogenesis pathogenic mechanisms Patient patients with COVID-19 Prevent Prognosis proportion recent regimen reported respiratory risk of COVID-19 SARS-CoV-2 self-tolerance Severe acute respiratory syndrome severe COVID-19 infections severe disease similarities similarity syndrome systemic lupus erythematosus therapeutic effect treat Trigger
[DOI] 10.1097/BOR.0000000000000776 PMC 바로가기 [Article Type] Review

Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials

Original research

Published on 2021-02-172024-09-04
Journal: Lupus science & medicine [Category] 대상포진,

[키워드] Biological products Health care Interferon type I lupus erythematosus outcome assessment systemic Therapeutics
[DOI] 10.1136/lupus-2020-000464 PMC 바로가기 [Article Type] Original research

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection

하이드록시클로로퀸 및 SARS-CoV-2 감염을 통한 만성 치료

Article

Published on 2021-02-012022-09-11
Journal: Journal of medical virology [Category] SARS, 신약개발, 치료기술, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age anonymized data antimalarial antimalarial drug Arthritis Autoimmune diseases Chemotherapy chemotherapy < chronic confirmed case coronavirus Corticosteroid Corticosteroids Cross linking database disease disease control Diseases economic reason < HCQ Hydroxychloroquine hydroxychloroquine sulfate immunosuppressants Infection Laboratory lupus erythematosus management medical prescriptions negative patients Odds ratio Patient proportion public policy public policy < receiving Registered repositioning respiratory rheumatoid arthritis SARS Coronavirus SARS coronavirus < SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positive patients severe acute respiratory syndrome Coronavirus Sex social science sulfate systemic lupus erythematosus treat treated Treatment virus virus classification
[DOI] 10.1002/jmv.26286 PMC 바로가기 [Article Type] Article

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic

Comment

Published on 2021-01-012023-07-13
Journal: Annals of the rheumatic diseases [Category] SARS,

[키워드] Arthritis Hydroxychloroquine lupus erythematosus Rheumatoid systemic
[DOI] 10.1136/annrheumdis-2020-217557 [Article Type] Comment

Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy

Original research

Published on 2020-12-302024-09-04
Journal: RMD open [Category] 대상포진,

[키워드] lupus erythematosus lupus nephritis systemic Therapeutics
[DOI] 10.1136/rmdopen-2020-001490 PMC 바로가기 [Article Type] Original research

Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches

Review

Published on 2020-12-072023-08-30
Journal: Cells [Category] E형 간염,

[키워드] autoantibodies Autoimmunity B cells BAFF BLyS lupus erythematosus pemphigoid pemphigus skin Tertiary lymphoid structures
[DOI] 10.3390/cells9122627 PMC 바로가기 [Article Type] Review

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research

Original research

Published on 2020-11-112024-09-04
Journal: RMD open [Category] 대상포진,

[키워드] ankylosing Arthritis lupus erythematosus psoriatic Rheumatoid spondylitis systemic
[DOI] 10.1136/rmdopen-2020-001374 PMC 바로가기 [Article Type] Original research